M C Willingham

2.5k total citations
26 papers, 2.1k citations indexed

About

M C Willingham is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cell Biology. According to data from OpenAlex, M C Willingham has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Cell Biology. Recurrent topics in M C Willingham's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Glycosylation and Glycoproteins Research (6 papers). M C Willingham is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Toxin Mechanisms and Immunotoxins (8 papers) and Glycosylation and Glycoproteins Research (6 papers). M C Willingham collaborates with scholars based in United States. M C Willingham's co-authors include Ira Pastan, Laura Beguinot, Ira Pastan, Robert B. Dickson, Raymond M. Lyall, Richard Schlegel, Seiji Ito, John A. Hanover, Nancy Richert and Maria Gallo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

M C Willingham

26 papers receiving 1.9k citations

Peers

M C Willingham
Andrew W. Brauer United States
Jos van Renswoude United States
Kirston Koths United States
Horst Ahorn Austria
F C Gaeta United States
R.B. Parekh United Kingdom
M C Willingham
Citations per year, relative to M C Willingham M C Willingham (= 1×) peers Stefan Müller

Countries citing papers authored by M C Willingham

Since Specialization
Citations

This map shows the geographic impact of M C Willingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M C Willingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M C Willingham more than expected).

Fields of papers citing papers by M C Willingham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M C Willingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M C Willingham. The network helps show where M C Willingham may publish in the future.

Co-authorship network of co-authors of M C Willingham

This figure shows the co-authorship network connecting the top 25 collaborators of M C Willingham. A scholar is included among the top collaborators of M C Willingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M C Willingham. M C Willingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pai-Scherf, Lee H., et al.. (1999). Hepatotoxicity in cancer patients receiving erb-38, a recombinant immunotoxin that targets the erbB2 receptor.. PubMed. 5(9). 2311–5. 89 indexed citations
2.
Johnson, Korey R., et al.. (1999). Apoptotic cell death induced by baccatin III, a precursor of paclitaxel, may occur without G 2 /M arrest. Cancer Chemotherapy and Pharmacology. 44(6). 444–452. 31 indexed citations
3.
Frankel, Arthur E., et al.. (1997). Therapy of Patients with T-cell Lymphomas and Leukemias Using an Anti-CD7 Monoclonal Antibody-Rich a Chain Immunotoxin. Leukemia & lymphoma. 26(3-4). 287–298. 66 indexed citations
4.
Johnson, Korey R., et al.. (1997). 5-Fluorouracil interferes with paclitaxel cytotoxicity against human solid tumor cells.. PubMed. 3(10). 1739–45. 49 indexed citations
5.
Fu, Tao, et al.. (1996). Ricin toxin contains three lectin sites which contribute to its in vivo toxicity. International Journal of Immunopharmacology. 18(12). 685–692. 16 indexed citations
6.
Scherf, Uwe, Ira Pastan, M C Willingham, & Ulrich Brinkmann. (1996). The human CAS protein which is homologous to the CSE1 yeast chromosome segregation gene product is associated with microtubules and mitotic spindle.. Proceedings of the National Academy of Sciences. 93(7). 2670–2674. 52 indexed citations
7.
Westerman, Marcus A., Ιωάννα Μαρουλάκου, Kelly W. Henderson, et al.. (1996). The down-regulated in adenoma (DRA) gene encodes an intestine-specific membrane glycoprotein.. PubMed. 12(2). 387–96. 74 indexed citations
8.
Frankel, Arthur E., Edward P. Tagge, & M C Willingham. (1995). Clinical trials of targeted toxins. Seminars in Cancer Biology. 6(5). 307–317. 53 indexed citations
9.
Kozak, Robert W., Haya Lorberboum‐Galski, Linda Jones, et al.. (1990). IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells.. The Journal of Immunology. 145(8). 2766–2771. 20 indexed citations
10.
Obata, Toru, et al.. (1989). A cytoplasmic thyroid hormone binding protein: characterization using monoclonal antibodies. Biochemistry. 28(2). 617–623. 15 indexed citations
11.
Gallo, Maria, Vijay K. Chaudhary, David Fitzgerald, M C Willingham, & Ira Pastan. (1988). Cloning and expression of the H chain V region of antibody OVB3 that reacts with human ovarian cancer.. The Journal of Immunology. 141(3). 1034–1040. 4 indexed citations
12.
FitzGerald, D J, M C Willingham, Carol Cardarelli, et al.. (1987). A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells.. Proceedings of the National Academy of Sciences. 84(12). 4288–4292. 120 indexed citations
13.
Beguinot, Laura, John A. Hanover, Seiji Ito, et al.. (1985). Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors.. Proceedings of the National Academy of Sciences. 82(9). 2774–2778. 180 indexed citations
14.
Beguinot, Laura, Raymond M. Lyall, M C Willingham, & Ira Pastan. (1984). Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes.. Proceedings of the National Academy of Sciences. 81(8). 2384–2388. 246 indexed citations
15.
Schlegel, Richard, Robert B. Dickson, M C Willingham, & Ira Pastan. (1982). Amantadine and dansylcadaverine inhibit vesicular stomatitis virus uptake and receptor-mediated endocytosis of alpha 2-macroglobulin.. Proceedings of the National Academy of Sciences. 79(7). 2291–2295. 151 indexed citations
16.
Willingham, M C & Ira Pastan. (1982). Transit of epidermal growth factor through coated pits of the Golgi system.. The Journal of Cell Biology. 94(1). 207–212. 123 indexed citations
17.
Dickson, Robert B., M C Willingham, & Ira Pastan. (1981). alpha 2-macroglobulin adsorbed to colloidal gold: a new probe in the study of receptor-mediated endocytosis.. The Journal of Cell Biology. 89(1). 29–34. 106 indexed citations
18.
Pastan, Ira & M C Willingham. (1981). Receptor-Mediated Endocytosis of Hormones in Cultured Cells. Annual Review of Physiology. 43(1). 239–250. 335 indexed citations
19.
Willingham, M C, Frederick R. Maxfield, & Ira Pastan. (1980). Receptor-mediated endocytosis of alpha 2-macroglobulin in cultured fibroblasts.. Journal of Histochemistry & Cytochemistry. 28(8). 818–823. 29 indexed citations
20.
Schlessinger, Joseph, Yoram Shechter, Pedro Cuatrecasas, M C Willingham, & Ira Pastan. (1978). Quantitative determination of the lateral diffusion coefficients of the hormone-receptor complexes of insulin and epidermal growth factor on the plasma membrane of cultured fibroblasts.. Proceedings of the National Academy of Sciences. 75(11). 5353–5357. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026